Ergoteles’s Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant IBER.U Stock Holding History

Ergoteles’s Portfolio IBER.U Stock Details IBER.U Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-13,850	Closed	-$137K	–	2087
2022 Q3	$137K	Hold	13,850	–	–	﹤0.01%	1299
2022 Q2	$136K	Hold	13,850	–	–	﹤0.01%	1443
2022 Q1	$137K	Hold	13,850	–	–	0.01%	1069
2021 Q4	$139K	Hold	13,850	–	–	0.01%	1106
2021 Q3	$138K	Hold	13,850	–	–	0.01%	1066
2021 Q2	$139K	Hold	13,850	–	–	﹤0.01%	1355
2021 Q1	$137K	Buy	+13,850	New	+$138K	﹤0.01%	714

Other funds holding IBER.U

Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return

Terrapin Asset Management Miami, Florida $87.8M AUM 16.84% 1-Year Est. Return

Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return

Susquehanna International Group

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Sage Mountain Advisors Atlanta, Georgia $1.43B AUM 16.47% 1-Year Est. Return

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return